US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 2.630
  • -0.010-0.38%
Close Nov 11 16:00 ET
  • 2.440
  • -0.190-7.22%
Pre 08:14 ET
187.86MMarket Cap-5057P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 3.254M --
-- 2024/Q4 -- / 5.646M --
-- 2024/Q3 4.346M / 11.849M --
-- 2024/Q2 2.766M / 1.817M --
May 7, 2024 2024/Q1 2.398M / 1.929M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.254M--
--2024/Q4-- / 5.646M--
--2024/Q34.346M / 11.849M--
--2024/Q22.766M / 1.817M--
May 7, 20242024/Q12.398M / 1.929M--

Unlock Free Earnings Estimates

Aclaris Therapeutics Earnings Reports

  • Aclaris Therapeutics | 10-Q: Quarterly report

    Nov 7 05:34

  • Aclaris Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 10:20

  • Aclaris Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 04:39

  • Aclaris Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 20:35

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data